Indonesia's president said on Thursday that he had asked Singapore, Russia, Malaysia and Japan for help to put out forest fires.» Read More
#1 biotech and pharma stock picks
The nation's largest pharmacy benefit manager plans to control costs from new cholesterol drugs through discounts and restricting use.
Three scientists have shared the Nobel Prize for medicine for work on key drugs used to fight parasitic diseases, the FT reports.
U.S. biotech shares extended their downward spiral on Tuesday as concerns about drug pricing continued to plague the sector.
There was a drop in the number of patients seen by doctors, who still had increased payments.
Spark Therapeutics plans to file for U.S. regulatory approval next year for the first gene therapy product on the market in the U.S.
MSF is leaving Kunduz after an airstrike on its hospital there on Saturday that killed 22 people, the NYT reports.
Morgan Stanley analyzed the drug pricing issue and found which companies are the best and worst positioned in a note sent to clients on Thursday.
Many companies at risk of the tax on high-cost health plans intend to avoid the levy.
After a string of young soccer players fall ill, June Leahy searches for answers on turf that could have caused her daughter's death, says NBC News
Doctors outside of insurance plan networks charge several times what Medicare would pay.
The fight for Planned Parenthood funding is far from over, says patient and advocate Dayna Ferris-Fisher.
Biotech stocks surged on Wednesday, and according to one trader, there are more gains ahead.
The real problem with biotech has to do with the size of biotech firms, says industry CEO Robert Mulroy. Here's why.
Sixty percent of people oppose the Obamacare levy on high-cost health plans — at first.
The most popular prescription drug plans will see an average price hike of 8 percent next year.
With the IBB performing poorly and increased confusion in the biotech market, is it time for investors to be bullish?
Hillary Clinton will speak out against the so-called Cadillac tax on certain health care plans. The NYT reports.
Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease.
Turing Pharmaceuticals may have been an egregious example of overnight drug price hikes, but it's not the only one raising eyebrows.
Get the best of CNBC in your inbox